Free Trial

Omega Healthcare Investors (NYSE:OHI) Given "Buy (B)" Rating at Weiss Ratings

Omega Healthcare Investors logo with Finance background

Omega Healthcare Investors (NYSE:OHI - Get Free Report)'s stock had its "buy (b)" rating reissued by research analysts at Weiss Ratings in a research report issued on Saturday,Weiss Ratings reports.

OHI has been the subject of a number of other research reports. Mizuho upped their price target on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a "neutral" rating in a report on Thursday, September 11th. Cantor Fitzgerald initiated coverage on Omega Healthcare Investors in a report on Wednesday, October 1st. They issued an "overweight" rating and a $50.00 price target for the company. Royal Bank Of Canada increased their target price on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research note on Thursday, August 7th. Raymond James Financial restated an "outperform" rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Finally, Wells Fargo & Company upped their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company an "overweight" rating in a report on Tuesday. Six research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $44.50.

View Our Latest Analysis on Omega Healthcare Investors

Omega Healthcare Investors Stock Down 0.5%

OHI opened at $40.48 on Friday. The firm has a 50 day moving average price of $41.59 and a 200 day moving average price of $39.02. The company has a market cap of $11.94 billion, a PE ratio of 24.99, a price-to-earnings-growth ratio of 1.89 and a beta of 0.70. Omega Healthcare Investors has a 1 year low of $35.04 and a 1 year high of $44.42. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last posted its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.45 by $0.32. The firm had revenue of $235.60 million during the quarter, compared to the consensus estimate of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company's revenue was up 11.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Sell-side analysts expect that Omega Healthcare Investors will post 2.86 earnings per share for the current year.

Insider Activity at Omega Healthcare Investors

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company's stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the transaction, the director directly owned 18,654 shares in the company, valued at $749,144.64. The trade was a 11.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.50% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of OHI. GAMMA Investing LLC raised its stake in shares of Omega Healthcare Investors by 14.2% in the first quarter. GAMMA Investing LLC now owns 4,572 shares of the real estate investment trust's stock valued at $174,000 after purchasing an additional 568 shares in the last quarter. Janney Montgomery Scott LLC raised its stake in Omega Healthcare Investors by 5.0% during the first quarter. Janney Montgomery Scott LLC now owns 34,453 shares of the real estate investment trust's stock worth $1,312,000 after acquiring an additional 1,651 shares in the last quarter. Oppenheimer Asset Management Inc. raised its stake in Omega Healthcare Investors by 17.2% during the first quarter. Oppenheimer Asset Management Inc. now owns 31,736 shares of the real estate investment trust's stock worth $1,209,000 after acquiring an additional 4,669 shares in the last quarter. Illinois Municipal Retirement Fund raised its stake in Omega Healthcare Investors by 37.7% during the first quarter. Illinois Municipal Retirement Fund now owns 36,729 shares of the real estate investment trust's stock worth $1,399,000 after acquiring an additional 10,058 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC raised its stake in Omega Healthcare Investors by 556.1% during the first quarter. Allspring Global Investments Holdings LLC now owns 1,028,187 shares of the real estate investment trust's stock worth $39,143,000 after acquiring an additional 871,472 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

About Omega Healthcare Investors

(Get Free Report)

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

Recommended Stories

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Omega Healthcare Investors Right Now?

Before you consider Omega Healthcare Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.

While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.